We report the synthesis of dicarboxylic acid-terminated polyethylene-glycol (PEG)-gold nanoparticles by a simple one-step method, and their further use to form nanostructured surfaces for biomolecule immobilization. The synthesized nano-scale particles were conjugated with probe/target oligonucleotides in order to evaluate intercalation phenomenon in the presence of doxorubicin drug via Surface Enhanced Raman Spectroscopy (SERS) analysis.
Introduction
Gold nanoparticles (AuNPs) have attracted increasing attention due to their unique properties and interest in multiple research areas 1,2 AuNPs exhibit different optical, electromagnetic and catalytic properties, from the bulk metal making them suitable for various nanotechnological applications 2-4 .
Recently, great advances have been made in the use of gold nanoparticles, for biomedical applications, owing to their stability, chemical reactivity, non-toxic nature and strong absorption and scattering properties 5, 6 . For instance biomolecule-and/or biopolymerconjugated AuNPs are largely used as biomarkers or biodelivery vehicles, as well as for cosmetics, as anti-aging components for skin protection 7, 8 . Therefore, more attention should be paid on efficient synthesis methods to match the enlarging demand of AuNPs. In the synthesis of nanoparticles a key role is played by the stabilizers, not only to avoid particle aggregation but also control their functional properties. To date, a variety of stabilizers have been employed for the synthesis of AuNPs [9] [10] . Most of them are toxic, and the removal of excess stabilizer causes unwanted aggregation of the particles, which is a matter of concern for various clinical applications 11 .Biver et al 12 synthesized Au nanoparticles using thioalkylated oligoethylene glycols functionalized with various fluorescent Acridine Orange derivatives 13 . Exchange of organic molecules on Au nanoparticles with PEG can inded be performed to prepare biocompatible PEG-stabilized Au nanoparticles 5 . Wang et al.
synthesized a Polyethylene glycol (PEG)-modified gold nanoparticle complex by one-step reaction by synchrotron x-ray irradiation method 14, 15 . A low concentration of unmodified PEG macromolecules is very important to control particle size and stabilize gold nanoparticles demonstrate high stability under realistic biomedical conditions 16 . Other approaches were applied to stabilize gold nanoparticles using sulfur-containing polymers, with a possible limitation of their suitability for specific biomedical application. As an example of biocompatible functionalization, polyethylene glycol (PEG) and poly N-vinyl-2-pyrrolidone (PVP) were exploited to modify nanovectors for gene drug/delivery [17] [18] [19] , tumor targeting 20, 21 A c c e p t e d M a n u s c r i p t and x-ray imaging 22 . For in vivo applications using PEG-gold nanoparticles, all the preparations were based on conventional methods (i.e.sodium citrate or sodium borohydrate reduction) and post-addition of thiolated PEG leading to gold particles usually larger than 20 nm 23 . Futhermore, the high cost of thiolated PEGs could limit commercial applications. And now as it is being synthesized with appropriate size scale and desired structures, it is getting much more enthusiasm such as biomedical applications particularly in targeted drug delivery therapy by one step approach. The multifunctional doxorubicin (DOX) conjugated AuNPs (DOX-AuNPs) may also be used to improve imaging contrast for photothermal cancer therapy 24 . Up to now DOX (figure 1) has been considered as an effective anticancer drug and its activity is apparently related to the direct interactions with dsDNA 25, 26 , Therefore DOX is an inhibitor of the topoisomerase II and can inhibit DNA duplication and transcription to mRNA 27 . DOX-AuNPs facilitate intracellular drug delivery overcoming multidrug resistance in cancer cells 28 . The study of small ligands interacting with nucleic acids is a major area of research that has particular relevance in our understading of drug-DNA interactions involved in chemoterapeutic applications.From these studies it is known that drug binding can have many distinct modes including intercalation, and cross linking. We report here a one-solution synthesis to prepare polymer-modified gold nanoparticles using dycarboxylic PEG as stabilizer. We have thus implemented and evaluated a simple and reproducible method for labeling biomolecules with PEG gold nanoparticles without utilizing organic solvents and surfactants in order to improve the ability of drug molecules to reach specific cellular site and be easily released. The successive steps of functionalized PEG gold nanoparticle synthesis, as well as oligonucleotides and Doxorubicin grafting, have been characterized by Raman measurements.
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Experimental Section

Materials
Tetrachloroauric Acid (HAuCl 4 ), sodium borohydride (NaBH 4 ), N-hydroxysuccinimide (NHS), and characterized using UV-Vis spectroscopy and transmission electron microscopy (TEM).
Characterization methods:
The schematic diagram of the chemical immobilization method is depicted in scheme 2
SAMs formation:
Self-assembling monolayers (SAMs) offer the possibility to modify the terminal functions of thiol-chains to bind any type of ligands by covalent, ionic or hydrogen interactions .Chemical procedures, based on SAMs of Cysteamine in absolute ethanol, have been described M a n u s c r i p t previously 31 . Briefly the freshly cleaned gold substrate was immersed in an unstirred 10 mM ethanol solution of β-mercaptoethylamine (cysteamine) at room temperature, in the dark, for 6h. The gold substrate was then washed with ethanol and milli Q water to remove the excess of thiol ( scheme 2a).
PEG-AuNPs covalent grafting on Cysteamine Gold substrates :
2 ml of PEG-AuNPs were dissolved in 2 ml of buffer solution (PBS pH 7), in which ½ eq of EDC/NHS was added, and stirred for 2h (pre-activation). The colloidal solution was deposited on cysteamine-gold-coated surface for 12h at room temperature ( scheme 2b).
Oligonucleotide linking to pegylated gold nanostructured surface:
The gold substrate, after PEG-AuNPs covalent grafting, was treated with a solution of NHS (50 mg) and EDC (80 mg) in 3 mL of water for 4h (activation) and then immersed successively in these solutions of Oligonucleotide in PBS buffer solution (pH 7). These experiments were carried out 4 times at room temperature leading to very similar results.
Probe Oligonucleotide (NH2-AAC-CAT-AAT-TAA-AAA-TAC-CTC-TAA-C) (100 microlitre /L in buffer solution) was deposited on the PEG-nano Au chip surface. After 1h, the surface was rinsed with buffer solution then with milli Q water for 1h . After this time, the surface was then washed with buffer, water and dried under a stream of nitrogen. The procedure was repeated two twice. Hybridization interaction was then evaluated by Oligonucleotide complementary target (GTT-AGA-GGT-ATT-TTT-AAT-TAT-GGT-T) during 1h. After this time, the surface was rinsed with buffer solution then with milli Q water and dried by the same procedure ( scheme 2c).
Bioconjugation of Doxorubicin to Au-PEG Nanoparticles
Bioconjugation of Doxorubicin to PEG-AuNPs (DOX-PEG-AuNPs) was described previously 31 . Briefly, 20 μl of an aqueous solution of EDC-NHS (80mg/20mg) solution was added into 5 mL of PEG-AuNPs. After 2h, doxorubicin( 1mL, 1μM) was added and aged for 2h and then centrifuged 3 times and redispersed in PBS solution to remove of unbound M a n u s c r i p t
DOX. Scheme 2 e shows a schematic representation of the interaction between DOX-PEG-
AuNPs and Oligonucleotides onto gold nanostructured surface , compared to the DOX free interaction in the same conditions ( scheme 2c), in order to detect in a sensitive manner DNA hybridisation and intercalation events.
Techniques
UV-Vis Absorption Spectroscopy.
All the absorption spectra reported in this work have been recorded using a double-beam
Varian Cary 500 UV-Vis spectrophotometer. In particular, absorption spectra of the PEG-AuNPs were recorded in the 300-980 nm spectral range.
SEM & TEM
SEM images were obtained using a SEM FEG Hitachi SU-70 scanning electron microscope with a low voltage of 1 kV, and distance of 1.5-2 mm; the secondary electron detector "in Lens" was used. 50 μl of colloidal solution was deposited onto a clean gold substrate and dried at room temperature for the SEM images.
Transmission electron microscopy measurements were recorded on a JEOL JEM 1011 microscope operating at an accelerating voltage of 100 KV. The TEM graphs were taken after separating the surfactant from the metal particles by centrifugation. Typically 1mL of the sample was centrifuged for 20 min at a speed of 14000 rpm/min. The upper part of the colourless solution was removed and the solid portion was re-dispersed in 1 ml of water. 2 μL of this re-dispersed particle suspension was placed on a carbon coated copper grid and dried at room temperature.
SERS Spectroscopy:
SERS Surface-enhanced Raman scattering spectra were recorded in the 500-1,900 cm−1 range on a modular Raman spectrometer (Model HL5R of Kaiser Optical Systems, Inc.) equipped with a high-powered near-IR laser diode working at 785 nm. Before spectra acquisition, an optical microscope (Olympus; objective, ×50) was used to focus the laser beam. Measurements were carried using an objective ×100. The laser output power was 10 A c c e p t e d M a n u s c r i p t mW, which corresponds to ∼1 mW on samples. For each spectrum, 30 acquisitions of 5 s were recorded to improve the signal-to-noise ratio. To ensure a representative characterization of surfaces, a minimum of three measurements were taken on different parts of the surface. 
Results
Synthesis and bioconjugation of PEG-AuNPs
SERS analysis of the interaction between DOX-PEG-AuNPs and oligonucleotides:
Pegylated Gold Nanostructured surface were functionalized with amino probe oligonucleotides and our complementary target in order to evaluate the enhancement of Raman Signal before and after interaction of free DOX molecules and DOX-PEG-AuNPs.
Stock solutions of doxorubicin, were prepared in phosphate-buffered saline (PBS at concentration of 10 -3 M and diluted to the 10 -8 M concentration before each experiment).
Experimental Raman (o SERS) spectra in the spectral range of 500-1900 cm -1 are shown in A c c e p t e d M a n u s c r i p t enhanced 40 . RAMAN spectrum was similar to that of free DOX molecules, except that all bands were broadened and the some new bands around 800-1100 cm -1 appeared. There is a blu-shift from 1372 cm -1 to 1312 cm -1 and a enhancement of the peak 1312 cm -1 due at the deformation of the hydrogen bond ,Ring C20/15 and C16-OH bending A prominent peak at 1123 cm -1 is due at C-N band and a small peak appears at 640 cm -1 may be due at C-S guanine 41 . The SERS enanchement factor was calculated by comparing SERS signal excited of the DOX intercalated in DNA/DNA complex onto pegylated nanostructured surface before and after conjugation with PEG AuNPs. Here we adopted the estimation of the SERS enhancement factor reported by Gupta and Weimar 42 .Thus , the value of G was 0.47.
5.Discussion
Particles formation and growth were controlled by the amphiphilic (dual nature) character of the PEG-diacid polymers described previously 43, 44 . Other authors have reported the mechanism of gold nanoparticles formations in presence of poly (ethylene oxide)-poly (propylene oxide)-poly (ethylene oxide) block copolymers (PEO-PPO-PEO) varying temperature and solvent quality 45 .This block copolymers bind metal ions 45 , and reduction of bound AuCl 4 ions can proceed via oxidation of the oxyethylene and oxypropylene segments by the metal center 45 . The main difference with other synthetic procedures of PEG-AuNPs is that PEG-diacid is used in the same way as citrate for the stabilization of the particles through electrostatic interactions between the carboxylic acid groups and the gold surface 44 . manner. This approach will be extended to the realization of pegylated gold nanostructured surfaces in which different longer chains and functional groups of PEG polymers will be utilized to conjugate many type of tumoral biomarker in order to monitor the release of DOX in cancer cells.
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